Aripiprazole in Adolescents With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole tablet, 10 mg

Aripiprazole tablet 10 mg po qd x 42 days

DRUG

Aripiprazole tablet, 30 mg

Aripiprazole tablet 30 mg po qd x 42 days

DRUG

Placebo tablet

Placebo tablet po qd x 42 days

Trial Locations (55)

Unknown

Local Institution, Birmingham

Local Institution, Little Rock

Local Institution, Costa Mesa

Local Institution, Los Angeles

Local Institution, National City

Local Institution, Orange

Local Institution, Pasadena

Local Institution, Sacramento

Local Institution, San Diego

Local Institution, Temecula

Local Institution, Washington D.C.

Local Institution, Altamonte Springs

Local Institution, Fort Lauderdale

Local Institution, Gainesville

Local Institution, Hialeah

Local Institution, Jacksonville

Local Institution, Miami

Local Institution, North Miami

Local Institution, Orange City

Local Institution, Tampa

Local Institution, Newnan

Local Institution, Smyrna

Local Institution, Honolulu

Local Institution, Chicago

Local Institution, Kansas City

Local Institution, Lexington

Local Institution, Lake Charles

Local Institution, New Orleans

Local Institution, Medford

Local Institution, Clinton Township

Local Institution, Flowood

Local Institution, Kansas City

Local Institution, Las Vegas

Local Institution, Elmsford

Local Institution, New York

Local Institution, Olean

Local Institution, Rochester

Local Institution, Chapel Hill

Local Institution, Cleveland

Local Institution, Lyndhurst

Local Institution, Oklahoma City

Local Institution, Bala-Cynwyd

Local Institution, Philadelphia

Local Institution, Memphis

Local Institution, Bellaire

Local Institution, DeSoto

Local Institution, Houston

Local Institution, San Antonio

Local Institution, Salt Lake City

Local Institution, Richmond

Local Institution, Kirkland

Local Institution, Spokane

Local Institution, Wauwatosa

Local Institution, Rio Piedras

Local Institution, San Juan

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00102063 - Aripiprazole in Adolescents With Schizophrenia | Biotech Hunter | Biotech Hunter